Cristiana Alberghina, Filippo Torrisi, Simona D'Aprile, Lucia Longhitano, Sebastiano Giallongo, Grazia Scandura, Giuliana Mannino, Stefania Mele, Maria Gabriella Sabini, Francesco P Cammarata, Giorgio Russo, Ali S Abdelhameed, Agata Zappalà, Debora Lo Furno, Rosario Giuffrida, Giovanni Li Volti, Daniele Tibullo, Nunzio Vicario, Rosalba Parenti
Glioblastoma (GBM), a WHO grade IV glioma, is a malignant primary brain tumour for which combination of surgery, chemotherapy and radiotherapy is the first-line approach despite adverse effects. Tumour microenvironment (TME) is characterized by an interplay of cells and soluble factors holding a critical role in neoplastic development. Significant pathophysiological changes have been found in GBM TME, such as glia activation and oxidative stress. Microglia play a crucial role in favouring GBM growth, representing target cells of immune escape mechanisms...
March 7, 2024: Cell Proliferation